~~<i id='C3C092418F'><strike id='C3C092418F'><tt id='C3C092418F'><pre id='C3C092418F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：focus 2025-09-06 02:11:04 - browse：6192

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Lawmakers grill UnitedHealth CEO on Change cyberattack

hotspot

explore

entertainment

focus

leisure time

Wikipedia

GarethCattermole/GettyImagesCialis,Eliquis,Jevtana,Xgeva.Thesedrugnamesmaysoundsilly,buttheprocessof

WSS

Deliver public health messages at the right time

Prosecutors seek bail revocation for FTX founder Sam Bankman

Pharma needs to include young adults in clinical research

Lawmakers grill UnitedHealth CEO on Change cyberattack

AI for drug discovery: Experts on separating hype from reality

GSK’s asthma push continues as drug succeeds in Phase 3 trials

entertainment

hotspot

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Has Bernie Sanders reached the limit of his pharma bullying effort?

How one medical school became remarkably diverse

Rock icon Freddie Mercury pre

Virginia high school admissions case could be legal follow

BIO to announce reorganization, senior leaders expected to depart

Wildfire smoke exposes gaps in outdoor worker protections

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

In age of alternative facts, a scholarly course on calling out crap

Scientists find bacteria from stomach of ancient iceman

explore

Primary care doctor shortage won't be solved by free med school tuition

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Brain technologies pose threats that are all too real, experts warn

AI for drug discovery: Experts on separating hype from reality

AI for drug discovery: Experts on separating hype from reality

entertainment

focus

leisure time

Wikipedia